News
MaxCyte, Inc. - Notice of Results
RNS Number: 7153 O MaxCyte, Inc. 02 February 2023 MaxCyte to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023 and Participate in Upcoming Investor Conferences. ROCKVILLE, MD, February 2, 2023- MaxCyte, Inc.,, a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development...
sup{font-size:80%}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: #954F72 } .z{size:612.0pt 792.0pt;margin:72.0pt 72.0pt ...